medspa mastery logoSubscribe to The Medspa Mastery Report: The Go-To Hub for News, Tools, and Growth in the Aesthetic Industry.

šŸ’‰ Ohio Doctors Disciplined Amid Rising Concerns Over Weight-Loss Drug Practices| šŸ’” CDC Investigating Botox related illnesses in Tennessee and Illinois | šŸƒ TEXAS Bill Authorizes Cosmetic Injections for Dentists| Journey Medical's Emrosi Rosacea Pill Receives FDA Approval | Merz Studay Reveals Aesthetic Procedures Impact Self-View | šŸ’” Evolus Prepares to launch Evolysseā„¢ ahead of schedule | šŸ›‘ Ohio Doctors Disciplined Amid Rising Concerns Over Weight-Loss Drug Practices | šŸŸ¤ NORTH DAKOTA Bill Would License Advanced Estheticians | šŸšØ TEXAS Bill Authorizes Cosmetic Injections for Dentists | Skinbetter Science Launching New Face and Neck Treatment Cream | šŸ’‰ Flawless Medspa & Wellness Joins Alpha Aesthetics Partners'| šŸƒ Remembering Dr. Loretta Ford - Co-founder of the Nurse Practitioner | šŸŸ¤ NORTH DAKOTA Bill Would License Advanced Estheticians| Skinbetter Science Launching New Face and Neck Treatment Cream |

Allergan Aesthetics, an AbbVie company, has announced the launch of its AA Signature Program at IMCAS 2025, a move set to redefine patient-centric, multimodal treatment planning in aesthetics. This new initiative underscores the companyā€™s commitment to advancing aesthetic medicine by integrating science-driven, personalized protocols that address diverse patient needs.

“This program represents a new era in aesthetic medicine,” said Carrie Strom, President of Global Allergan Aesthetics. “By offering tailored, science-backed treatment frameworks, we’re empowering practitioners to deliver the best possible outcomes for their patients.”

What is the AA Signature Program?

The AA Signature Program is designed to equip aesthetic practitioners with comprehensive treatment frameworks that align with evolving patient expectations. This approach moves beyond singular treatment modalities, encouraging providers to combine multiple Allergan Aesthetics products and techniques to achieve optimal, natural-looking results.

A Shift Toward Personalization in Aesthetic Medicine

As aesthetic medicine evolves, patient demands are shifting toward more customized, holistic approaches. The AA Signature Program prioritizes individualized treatment plans, blending neuromodulators, dermal fillers, and other Allergan Aesthetics innovations to create tailored outcomes. The initiative also emphasizes education, offering aesthetic professionals access to expert-led guidance and evidence-based methodologies.

IMCAS 2025: A Strategic Platform for Innovation

The programā€™s debut at IMCAS 2025, a leading global congress for aesthetic and anti-aging medicine which runs from Jan 30-Feb 1 in Paris, highlights Allergan Aestheticsā€™ dedication to fostering industry collaboration. By unveiling the AA Signature Program on this international stage, the company aims to engage top practitioners, educators, and researchers in discussions on the future of multimodal treatments.

Learn more about IMCAS 2025 and Allergan Aestheticsā€™ initiatives here.

imcas 2025 paris france

What This Means for Medspa Owners and Providers

For medspa owners and aesthetic providers, the AA Signature Program offers a structured way to elevate patient outcomes and differentiate their services. By adopting a multimodal approach, practitioners can enhance treatment efficacy, patient satisfaction, and long-term loyalty.

Stay tuned to Medspa Mastery for ongoing coverage of IMCAS 2025 and the latest innovations in aesthetic medicine.

Enter your email for exclusive content from The Medspa Mastery Report delivered to your inbox weekly.

Please enable JavaScript in your browser to complete this form.